• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Fragile X Syndrome

Fragile X Syndrome - 27 Studies Found

Completed : Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
: Fragile X Syndrome
: 2011-05-18
:
  • Drug: AFQ056
  • Drug: Placebo

Completed : Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome
: Fragile X Syndrome
: 2016-01-25
:
  • Drug: Minocycline, then Minocycline/Lovastatin

Terminated : Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome
: Fragile X Syndrome
: 2011-05-03
: Drug: AFQ056 The investigational drug, AFQ056, will be provided as hard gelatin capsules. Two different
Terminated : Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)
: Fragile X Syndrome
: 2011-08-31
: Drug: AFQ056 The investigational drug, AFQ056, will be provided as hard gelatin capsules. Two different
Completed : Riluzole in Fragile X Syndrome
: Fragile X Syndrome
: 2009-05-06
: Drug: Riluzole Six week open-label treatment with riluzole, maximum dose of 50 mg twice a day.
Completed : A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
: Fragile X Syndrome
: 2007-01-09
: Drug: Aripiprazole All subjects will initially receive 2.5 mg/day of aripiprazole during the first week.
Completed : Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome
: Fragile X Syndrome
: 2011-03-29
:
  • Dietary Supplement: Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin

Completed : An Open-Label Trial of Donepezil in Fragile X Syndrome
: Fragile X Syndrome
: 2005-09-15
: Drug: donepezil donepezil 5 mg daily for 3 weeks (days 1-21); 10 mg daily for 3 weeks (days 22-42)
Completed : Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome
: Fragile X Syndrome
: 2009-03-09
: Drug: Minocycline 50-100 mg PO BID for 8 weeks with an option for a 1 year extension.
Completed : Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome
: Fragile X Syndrome
: 2010-12-02
:
  • Drug: placebo intranasal place

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.